Clinical Studies

Clinical research is very important because it is one of the best ways to improve patient care. Currently, hundreds of studies are taking place throughout Lurie Children's, including at the research institute, that involve many of our doctors, nurses, clinical research professionals, scientists and technicians.

Search below for a clinical study, or to see a more comprehensive listing of the clinical studies taking place at Lurie Children's, please use our link to the ClinicalTrials.gov website.

You can learn more about the clinical research process on our guide to clinical research for parents and children.

Filter by:

Studies

STOP PIV - Phase 3 DAS181 Lower Tract PIV Infection in Immunocompromised Subjects

ClinicalTrials.gov ID: NCT03808922

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection

BIOPIC: Fungal Biomakers for Diagnosis and Response to Therapy for Pediatric Candidemia

ClinicalTrials.gov ID: NCT 02220790

This study will create an international multi-center cohort of children with new clinical concern for infecton while in the hospital.  Sites used are part of the International Pediatric Fungal Network (ipfn.org).  The study plans to prospectively enroll pediatric patients at high-risk of developing invasve candidiasis over a four year...

Evaluating the Safety and Pharmacokinetics of VRC01, A Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1 Exposed Infants

ClinicalTrials.gov ID: NCT02256631

VRC01 and VRC01LS are anti-HIV neutralizing monoclonal antibodies that may help prevent mother-to-child transmission of HIV. This study will enroll HIV-infected mothers who are at increased risk of passing HIV on to their children. The purpose of this study is to assess the safety and PK of VRC01 and VRC01LS in HIV-exposed infants. This study will...

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants (MELODY)New Page

ClinicalTrials.gov ID: NCT 03979313

This pivotal Phase 3 study will determine if MEDI8897 will prevent medically attended RSV-confirmed lower respiratory tract infections (LRTI) in healthy infants entering their first RSV season. The population to be enrolled is healthy late preterm and term infants born 35 weeks 0 days or greater gestational age (GA) who would not be eligible to...